vsportÌåÓýƽ̨

À´Ô´£ºÁôѧÉú´©´î  £¬×÷Õߣº  £¬£º

ÄãÏþµÃû  £¬ÁøÖÝÍíÉÏÄǵã×ÓÉú»î¸ãµÃÂéÖ±ÊÇñ²µÄ  £¬²»¹ÜÊdzԵĺȵÄÕÕ¾ÉÍæµÄ  £¬ÂÛÌì¶¼²»ÅÂÄãûµØ·½¿Ë¡£½²µ½ÑŽ­Õâ¸öµØ·½  £¬¸üÊÇÐÑÁúµ½ÂÑÃÍ  £¬Ã»µÃ½²¡£½ñÌì¾Í¸úÄã´µ´µ  £¬ÑŽ­ÍíÉÏË£¿ì²ÍµÄµØ·½¾¿¾¹Óжàµð¸Ü¡£

ÑŽ­Ò¹ÍíµÄ¿ì²Í³¡¾°  £¬ÂÑÊǵĸ»ºñ

½²µ½ÑŽ­  £¬ÍíÉÏÄÇ¿­Óи㣿ÂѶàÁË£¡Äã´ÓÑŽ­ÇÅͷһ·ÔúÈ¥  £¬ÕûÌõ½Öͷβ¶¼ÊÇ¿ì²Í̯  £¬ÂÑ»ðÌ̵ÄÉÕ¿¾¡¢ÂéÀ±ÌÌ¡¢³´·Û³´·¹  £¬ÖÖÖÖÏãζ¸ãµÃÄãÍ·¶¼×ª²»Çå¡£ÓÈÆäÊÇÄÇÖÖС̯̯  £¬ËäÈ»¿´ÆðÀ´ÆßºÚ°ËºÚ  £¬µ«ÂÑºÃ³Ô  £¬³Ôµ½Ë¬µ½ÂѶ¼µø¡£

ÓÐÐ©Ì¯Ì¯ÌØ±ðÓл¨Í·  £¬ÏñÄǸö¡°ÀÏÁõÉÕ¿¾Ì¯¡±  £¬Ëû¼ÒµÄ¿¾ÇÑ×Ó¸ãµÃÂÑÏã  £¬Ò»¸ö̯̯¾Í¼·ÂúÈË  £¬ÂÑÊǵÄÅŶÓ¡ £ÁíÓС°°¢¾êС³´¡±  £¬ÖíÔÓ·ÛÂÑÃ͵ÃÄã²»ÏþµÃ¸ü×ÓÐÎÈÝ¡£ÄãÒªÊÇÃÆÍ·¼¦Ò»ÑùûÌåÑé¹ý  £¬¶ªÄÇÐÇ  £¬ÕæÊÇÀ˲ÙÐÄÇé¡£

ÑŽ­µÄ¿ì²Í¼Û¸ñ  £¬Ã»Ñ¹Á¦

ÓÐЩÈË¿ËÑŽ­Íæ  £¬ÂÑųԲ»Æð¡£à¸¸úÄ㽲࣠ £¬Ã»µÃ½²  £¬ÑŽ­µÄ¿ì²Í¼Û¸ñÂÑ×ÔÖÆ  £¬Ò»Íë·ÛÒ²¾ÍÊ®¼¸¿é  £¬ÉÕ¿¾Ò»´®Á½Èý¿é  £¬ºÈµãÆ¡¾Æ¼Óµã»¨ÉúÂÑ»®Ëã¡£½²µ½ÕâÀï  £¬Èç¹ûÄãÊÇѧÉúµ³»òÕ߸ճöÀ´´òÆ´µÄèt¨¤i  £¬ÕâÀïÊÇÄãÍíÉÏË£µÄÐÑéÏ魵ء£

¿ì²Í̯µÄÇé¿ö  £¬ÂÑ»ðÌÌ

½²ÊµÔÚ»°  £¬ÑŽ­µÄ¿ì²Í̯Çé¿öÂѰ¤ÂÑÁË  £¬ÍíÉÏÆß°Ëµã¿ªÊ¼  £¬Ì¯Ì¯É϶¼¹ÒÂúµÆµ¨  £¬ÕÕµÃÂéÖ±ÁÁ¡£×øÔÚ½­±ß³Ô¹¤¾ß  £¬´µ×Ž­·ç  £¬Ìý×ÅÅÔ±ßÈý½Å赯¼ªËû  £¬»¹ÄÜ˳±ãÐÀÉÍÁø½­Ò¹¾°  £¬ÂÑÊǵÄÓÐÇéµ÷¡£

Ïà¹ØÍ¼Æ¬
ÐÑÁúµã£ºÑŽ­¿ì²Í̯  £¬×îºÃ¿ËÔçÒ»µã  £¬Ã»È»ÂѼ·ÈË  £¬¸ãÂÑû¼û  £¬³Ô¸ö·Û¶¼³ÉÎÊÌâ¡£

ÑŽ­ÍíÉϳýÁË³Ô  £¬»¹Äܸãµã¸ü×Ó

³ýÁË¿ì²Í  £¬ÄãÏþµÃû  £¬ÑŽ­ÍíÉÏ»¹Äܸãµã¸ü×ÓÊÂÇé¡£ÒªÊDz»Ïë³ÔÁË  £¬¿ÉÒÔÈ¥½­±ßÉ¢²½  £¬»òÕßÕÒ¸ö¾Æ°ÉºÈÁ½±­¡£ÄÇÀïÓÐЩ¾Æ°É¸ãµÃÂÑÀËÂþ  £¬Æ¡¾Æ¡¢¼¦Î²¾ÆËæ±ãÑ¡  £¬Ìý×ÅÏÖ³¡ÒôÀÖ  £¬ÂÑÊǵÄËÉ¿ª¡£


ÄǾ¿¾¹ÑŽ­ÍíÉÏ¿ì²Íֵ̯µÃ²»ÖµµÃ¿Ë£¿ÂÑÊǵģ¡Äã¾Í¼Ç×ÅÒ»µã£º×ÔÖÆÓÖºÃ³Ô  £¬ÁøÖÝÒ¹Éú»î¸ãµÃÂéÖ±Êǵð¸ÜµÄ¡£

ÑŽ­¿ì²Í, ÁøÖÝÒ¹ÊÐ, Ò¹Éú»î¹¥ÂÔ, ¿ì²ÍÌ¯ÍÆ¼ö, Áø½­ÃÀʳ

Ïà¹ØÍ¼Æ¬

¡¶ËÕÖݳÇÖдå50Ôª¿ì²ÍÔÚÄÄÀï¡·

Êг¡¹æÄ££ºÊ¯Ó¢¾§ÌåÔªÆ÷¼þ×÷Ϊµç×ÓÐÅÏ¢¹¤ÒµµÄ½¹µã»ù´¡²¿¼þ  £¬ÆäÉú³¤½ø³ÌÓëÏÂÓÎÓ¦ÓÃÁìÓòµÄÀ©ÕÅÉî¶È°ó¶¨  £¬½üÄêÀ´  £¬Ïû·Ñµç×Ó¡¢Í¨ÐÅÉ豸¡¢Æû³µµç×ÓµÈÖ§Öù¹¤ÒµÎȲ½À©ÈÝ  £¬ÎïÁªÍø¡¢ÐÂÄÜÔ´¡¢ÎÀÐÇͨÐŵÈÐÂÐËÈüµÀ¼ÓËÙáÈÆð  £¬Ë«ÖØÇý¶¯Á¦ÅäºÏÀ­¶¯Ê¯Ó¢¾§ÌåÔªÆ÷¼þµÄÊг¡ÐèÇóʵÏÖ¿ìËÙÔö³¤  £¬Óë´Ëͬʱ  £¬¹ú¼Ò²úÒÃ÷ÈÕþ²ßÁ¬ÐøÏò»ù´¡µç×ÓÔªÆ÷¼þÁìÓò¶¨ÏòÇãб  £¬ÎªÐÐÒµ¹ú²úÌæ´ú½ø³ÌÓë¼¼ÊõÉý¼¶µü´ú×¢ÈëÇ¿¾¢¶¯ÄÜ  £¬ÔÚ´ËÅä¾°Ï  £¬º£ÄÚÆóÒµÔڸ߶˲úÆ·ÁìÓòµÄ¼¼Êõ¹¥¹ØÐ§¹ûÏÔÖø  £¬Öð²½Í»ÆÆ¹ú¼Êºã¾Ã¢¶Ï»¨Ñù  £¬Íƶ¯ÐÐÒµÀÖ³ÉʵÏִӵͶ˴ú¹¤Ïò¸ß¸½¼ÓÖµ»·½ÚµÄתÐÍÉý¼¶  £¬¾Ýͳ¼Æ  £¬2025ÄêÎÒ¹úʯӢ¾§ÌåÔªÆ÷¼þÐÐÒµÊг¡¹æÄ£´ï11.02ÒÚÔª  £¬Í¬±ÈÔö³¤18.8%  £¬Õ¼Ê¯Ó¢¾§ÌåÔªÆ÷¼þÐÐÒÃ÷ÈÕûÌ广ģµÄ26.14%¡£

¡¶Ä¿Ç°ÖØÇìÏ´Ô¡ÖÐÐÄÁíÓÐÉ«ÇéЧÀÍÂð¡·

ÀîÑÇÅô³Æ  £¬ÕâЩ¾è¿î½«ÓÃÓÚ×ÊÖúƶÀ§¼ÒÍ¥µÄ¶ùͯ½øÐÐÃâ·Ñ´½ëñÁÑÊÖÊõÖÎÁÆ¡£

¡¶ÉÜÐËÆ·²èÊÂÇéÊÒ¡·

ÉÏÖ¤±¨ÖйúÖ¤È¯ÍøÑ¶ ÃË¿ÆÒ©Òµ1ÔÂ28ÈÕÍíÐû²¼Í¨¸æ  £¬½üÈÕ¹«Ë¾È«×Ê×Ó¹«Ë¾MicuRx Pharmaceuticals, Inc.£¨¼´ÃË¿ÆÃÀ¹ú£©ÊÕµ½ÃÀ¹úʳƷҩƷ¼à¶½ÖÎÀí¾Ö£¨ÒÔϼò³Æ¡°USFDA¡±£©µÄ֪ͨ  £¬¹«Ë¾×ÔÖ÷Ñз¢µÄ¿¹¾úÐÂÒ©MRX-5ƬµÄÁÙ´²ÊÔÑéÉêÇëÒÑ»ñµÃUSFDAÅú×¼  £¬¿ÉÔÚÃÀ¹ú¿ªÕ¹ÁÙ´²ÊÔÑé¡£

ÍøÕ¾µØÍ¼